Approval · Notice of Compliance 15872 · 2014
SIMULECT: Notice of Compliance 15872
Issued July 24, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15872
- Date
- July 24, 2014
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site and changes to manufacturing process
- Therapeutic class
- Immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMULECT | Not yet assigned | — |
Medicinal ingredients
- BASILIXIMAB 20 MG per VIAL